Section Arrow
IRMD.NASDAQ
- iRadimed Corp
Quotes are at least 15-min delayed:2025/04/30 04:46 EDT
Last
 53.7
+0.68 (+1.28%)
Day High 
54.1399 
Prev. Close
53.02 
1-M High
54.1 
Volume 
20.06K 
Bid
21.6
Ask
85.91
Day Low
53 
Open
53.05 
1-M Low
47.4775 
Market Cap 
674.15M 
Currency USD 
P/E 35.35 
%Yield 1.15 
10-SMA 52.38 
20-SMA 51.84 
50-SMA 52.88 
52-W High 63.29 
52-W Low 40.55 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.50/2.03
Enterprise Value
674.15M
Balance Sheet
Book Value Per Share
6.83
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
73.24M
Operating Revenue Per Share
4.95
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed:2025/04/30 04:46 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.